Clinical Trials Logo

Opioid Antagonist clinical trials

View clinical trials related to Opioid Antagonist.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03430180 Enrolling by invitation - Clinical trials for Pathological Gambling

Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder

NalGamb
Start date: February 22, 2018
Phase: Phase 2
Study type: Interventional

Primary objective: *To determine whether treatment with naloxone hydrochloride nasal spray reduces gambling urge symptoms in patients with gambling disorder The secondary objectives of the study are: - To determine the effects of naloxone hydrochloride nasal spray on gambling severity, frequency and time, internet use, self-efficacy, quality of life, alcohol consumption, depression - To evaluate the safety of naloxone hydrochloride nasal spray in the treatment of gambling disorder